StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) income statement

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$5.57+1.05 (+23.12%)

Close on Nov 18, 2026Market cap $349.72MP/E –Yield –

Cytosorbents Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
71.6%
Operating margin
-34.7%
Net margin
-48.9%
Return on equity, FY2025
-96.4%

Financial strength

Current ratio
0.66
Debt to equity
-22.96
Debt to assets
45.4%
Cash to current liabilities
18.4%

Valuation

P/E ratio
–
Price to sales
9.40
Price to book
–
Dividend yield
–

See a number that looks wrong?